Inhibrx Biosciences, Inc. INBX Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Inhibrx Biosciences, Inc.’s reported figures.
Plus components not separately reported this period.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s total debt?
- Inhibrx Biosciences, Inc. (INBX) reported total debt of $180.9M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s total debt changed year-over-year?
- Inhibrx Biosciences, Inc.'s total debt increased by 69.8% year-over-year, from $106.53M to $180.9M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s total debt?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s total debt has grown at a -28.6% compound annual growth rate (CAGR), from $210.14M to $107.01M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.